Join Now

Category Archives: BioUtah News

Merit Medical Announces SCOUT Milestone: 750,000 Patients Treated with Wire-Free Technology

SCOUT Radar Localization use grows, supporting more successful surgeries and improved patient care.

| Tagged | Comments Off on Merit Medical Announces SCOUT Milestone: 750,000 Patients Treated with Wire-Free Technology

PhotoPharmics to Feature Photo Neurostimulation at the 2025 Movement Disorders Society International Congress

Attendees invited to Booth #732 for pivotal trial updates and to discuss unmet needs in Parkinson’s care.

| Tagged | Comments Off on PhotoPharmics to Feature Photo Neurostimulation at the 2025 Movement Disorders Society International Congress

Halia Therapeutics Named as 2025 Top 10 Longevity Breakthrough Award Winner

Halia Therapeutics Named as 2025 Top 10 Longevity Breakthrough Award Winner

| Tagged | Comments Off on Halia Therapeutics Named as 2025 Top 10 Longevity Breakthrough Award Winner

Seek Labs Advances Development of Pan-Orthopoxvirus Therapeutic with BioSeeker™ and PTAP™

BioSeeker mapped more than 10,000 isolates and identified targetable regions that provide 100% strain coverage across the viral family.

| Tagged | Comments Off on Seek Labs Advances Development of Pan-Orthopoxvirus Therapeutic with BioSeeker™ and PTAP™

Biolexis Therapeutics Initiates First-in-Human Clinical Trials for Novel, Oral Muscle-Sparing, Weight Loss and Type 2 Diabetes Therapies

Biolexis Therapeutics Initiates First-in-Human Clinical Trials for Novel, Oral Muscle-Sparing, Weight Loss and Type 2 Diabetes Therapies

| Tagged | Comments Off on Biolexis Therapeutics Initiates First-in-Human Clinical Trials for Novel, Oral Muscle-Sparing, Weight Loss and Type 2 Diabetes Therapies

FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Atopic Dermatitis in Children Ages 2 to 5

FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Atopic Dermatitis in Children Ages 2 to 5

| Tagged | Comments Off on FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Atopic Dermatitis in Children Ages 2 to 5

2025 MedTech Conference Sponsored by AdvaMed

This week AdvaMed held its annual Medtech Conference, designed for those in the medical technology industry.

| Comments Off on 2025 MedTech Conference Sponsored by AdvaMed

Nucleus Grow Hosts State of Innovation Conference

The State of Innovation Conference, hosted by The Nucleus Institute, brought together entrepreneurs, investors, policymakers, and researchers to explore pathways, partnerships, and funding strategies for breakthrough technologies. The day began with keynote speaker Jerry Hollister, who spoke on federal innovation funding trends, followed by a panel highlighting Utah companies that had successfully leveraged SBIR/STTR awards, […]

| Comments Off on Nucleus Grow Hosts State of Innovation Conference

Nelson Labs’ 40th Anniversary Celebration Recap

Nelson Labs on October 1 celebrated a milestone 40th anniversary. Since its humble beginnings in 1985 in University of Utah’s Research Park, Nelson Labs has grown into a trusted, global leader of medical device and pharmaceutical testing.

| Tagged | Comments Off on Nelson Labs’ 40th Anniversary Celebration Recap

ARUP’s Advanced Practice Laboratory: A National Model for Bridging Education and Industry

September 30, Salt Lake City—In a groundbreaking collaboration between ARUP Laboratories and the University of Utah, the new Advanced Practice Clinical Laboratory Training Center opened its doors this week and took a bold step toward solving a nationwide shortage of clinical laboratory scientists. This state-of-the-art facility is more than a training site; it’s a model […]

| Tagged | Comments Off on ARUP’s Advanced Practice Laboratory: A National Model for Bridging Education and Industry

Glafabra Therapeutics, Uncommon Cures Collaborate to Advance Fabry Disease Therapy

Glafabra Therapeutics, Uncommon Cures Collaborate to Advance Fabry Disease Therapy

| Tagged | Comments Off on Glafabra Therapeutics, Uncommon Cures Collaborate to Advance Fabry Disease Therapy

Seek Labs Selected as Participant of ARPA-H Investor Catalyst Hub Spoke Network, Rapid Response Partnership Vehicle

Seek Labs Selected as Participant of ARPA-H Investor Catalyst Hub Spoke Network and Rapid Response Partnership Vehicle (RRPV)

| Tagged | Comments Off on Seek Labs Selected as Participant of ARPA-H Investor Catalyst Hub Spoke Network, Rapid Response Partnership Vehicle